|
Gender
|
|
Male
|
115 (38.3)
|
|
Female
|
185 (61.7)
|
|
Age
|
|
Less than 30
|
31 (10.3)
|
|
30–60
|
163 (54.3)
|
|
More than 60
|
106 (35.3)
|
|
BMI
|
|
Normal weight (18.5–24.9)
|
65 (21.7)
|
|
Overweight (25–29.9)
|
136 (45.3)
|
|
Obese > 30
|
93 (31.0)
|
|
Educational statusa
|
|
Illiterate
|
20 (6.7)
|
|
Elementary
|
42 (14.0)
|
|
Primary
|
51 (17.0)
|
|
Secondary
|
54 (18.0)
|
|
University
|
124 (41.3)
|
|
Marital statusa
|
|
Married
|
229(76.3)
|
|
Unmarried (single, divorced, widowed)
|
67(22.3)
|
|
Income/month (NIS)a
|
|
Less than 2000
|
23 (7.7)
|
|
2000–5000
|
160(53.3)
|
|
More than 5000
|
108(36.0)
|
|
Employment statusa
|
|
Employed
|
194(64.7)
|
|
Unemployed
|
100(33.3)
|
|
Localitya
| |
|
Camp
|
36(12.0)
|
|
Rural
|
85(28.3)
|
|
Urban
|
172(57.3)
|
|
Chronic co-morbid diseasea
|
|
No co-morbid disease (pregnant)
|
42 (14.0)
|
|
One Disease
|
44(14.7)
|
|
Two diseases
|
63(21.0)
|
|
Three diseases or more
|
146(48.7)
|
|
Indications for anticoagulant
|
|
Atrial fibrillation
|
63 (21.0)
|
|
Deep vein thrombosis or Pulmonary embolism
|
29 (9.7)
|
|
Prophylaxisb
|
72 (24.0)
|
|
Other indications
|
136 (45.3)
|
|
Chronic medications
|
|
≤ 4
|
176(58.7)
|
|
> 4
|
124(41.3)
|
